🇺🇸 FDA
Patent

US 10568880

Glucocorticoid receptor modulators to treat cervical cancer

granted A61KA61K31/337A61K31/4745

Quick answer

US patent 10568880 (Glucocorticoid receptor modulators to treat cervical cancer) held by Corcept Therapeutics Incorporated expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/337, A61K31/4745, A61P, A61P35/00